To explore the mechanistic basis for the elevated fraction of CD44+/CD24−/low phenotype observed in normal and breast cancer cell populations following irradiation, we combined in vitro experiments with a cellular automata (CA) model to test mechanistic alternatives. This evidence concerns the gene CD44 and breast carcinoma.